Iguratimod as Treatment for Refractory Lupus Nephritis
Condition(s):Lupus NephritisLast Updated:February 27, 2017Unknown status
Hide Studies Not Open or Pending
Condition(s):Lupus NephritisLast Updated:February 27, 2017Unknown status
Condition(s):Lupus NephritisLast Updated:March 18, 2016Recruiting
Condition(s):Lupus Nephritis; Children; Steroid; Immunosuppressive TreatmentLast Updated:April 5, 2019Recruiting
Condition(s):Lupus NephritisLast Updated:January 23, 2024Active, not recruiting
Condition(s):Lupus NephritisLast Updated:October 17, 2022Terminated
Condition(s):Lupus NephritisLast Updated:December 1, 2020Completed
Condition(s):Lupus NephritisLast Updated:October 17, 2014Terminated
Condition(s):Lupus NephritisLast Updated:January 10, 2017Completed
Condition(s):Lupus Nephritis; ANCA Associated VasculitisLast Updated:February 26, 2024Recruiting
Condition(s):Acute Interstitial NephritisLast Updated:December 6, 2018Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.